Agilent Q1 Revenues up 2 Percent on Growth in Life Sciences and Addition of Dako | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Thursday a 2 percent bump in revenues during its fiscal first quarter but missed analyst estimates on the top and bottom lines.

Total revenues for the three months ended Jan. 31 came in at $1.68 billion, up from $1.64 billion during the first quarter of Fiscal Year 2012, but just short of the average analyst estimate of $1.69 billion.

Orders in the quarter reached $1.71 billion, a 6 percent increase from $1.62 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.